Cost-effectiveness of Pharmaceutical-based Pandemic Influenza Mitigation Strategies1
Identifieur interne : 000713 ( Ncbi/Merge ); précédent : 000712; suivant : 000714Cost-effectiveness of Pharmaceutical-based Pandemic Influenza Mitigation Strategies1
Auteurs : Anthony T. Newall ; James G. Wood ; Noemie Oudin ; C. Raina MacintyreSource :
- Emerging Infectious Diseases [ 1080-6040 ] ; 2010.
Abstract
Population prepandemic vaccine and antiviral treatment strategies may be cost-effective.
Url:
DOI: 10.3201/eid1602.090571
PubMed: 20113551
PubMed Central: 2957998
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 002455
- to stream Pmc, to step Curation: 002305
- to stream Pmc, to step Checkpoint: 002614
Links to Exploration step
PMC:2957998Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Cost-effectiveness of Pharmaceutical-based Pandemic Influenza Mitigation Strategies<xref ref-type="fn" rid="FN1"><sup>1</sup></xref></title><author><name sortKey="Newall, Anthony T" sort="Newall, Anthony T" uniqKey="Newall A" first="Anthony T." last="Newall">Anthony T. Newall</name></author><author><name sortKey="Wood, James G" sort="Wood, James G" uniqKey="Wood J" first="James G." last="Wood">James G. Wood</name></author><author><name sortKey="Oudin, Noemie" sort="Oudin, Noemie" uniqKey="Oudin N" first="Noemie" last="Oudin">Noemie Oudin</name></author><author><name sortKey="Macintyre, C Raina" sort="Macintyre, C Raina" uniqKey="Macintyre C" first="C. Raina" last="Macintyre">C. Raina Macintyre</name></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">20113551</idno><idno type="pmc">2957998</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2957998</idno><idno type="RBID">PMC:2957998</idno><idno type="doi">10.3201/eid1602.090571</idno><date when="2010">2010</date><idno type="wicri:Area/Pmc/Corpus">002455</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">002455</idno><idno type="wicri:Area/Pmc/Curation">002305</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">002305</idno><idno type="wicri:Area/Pmc/Checkpoint">002614</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">002614</idno><idno type="wicri:Area/Ncbi/Merge">000713</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Cost-effectiveness of Pharmaceutical-based Pandemic Influenza Mitigation Strategies<xref ref-type="fn" rid="FN1"><sup>1</sup></xref></title><author><name sortKey="Newall, Anthony T" sort="Newall, Anthony T" uniqKey="Newall A" first="Anthony T." last="Newall">Anthony T. Newall</name></author><author><name sortKey="Wood, James G" sort="Wood, James G" uniqKey="Wood J" first="James G." last="Wood">James G. Wood</name></author><author><name sortKey="Oudin, Noemie" sort="Oudin, Noemie" uniqKey="Oudin N" first="Noemie" last="Oudin">Noemie Oudin</name></author><author><name sortKey="Macintyre, C Raina" sort="Macintyre, C Raina" uniqKey="Macintyre C" first="C. Raina" last="Macintyre">C. Raina Macintyre</name></author></analytic><series><title level="j">Emerging Infectious Diseases</title><idno type="ISSN">1080-6040</idno><idno type="eISSN">1080-6059</idno><imprint><date when="2010">2010</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p>Population prepandemic vaccine and antiviral treatment strategies may be cost-effective.</p></div></front><back><div1 type="bibliography"><listBibl><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct></listBibl></div1></back></TEI><pmc article-type="research-article"><pmc-dir>properties open_access</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Emerg Infect Dis</journal-id><journal-id journal-id-type="publisher-id">EID</journal-id><journal-title-group><journal-title>Emerging Infectious Diseases</journal-title></journal-title-group><issn pub-type="ppub">1080-6040</issn><issn pub-type="epub">1080-6059</issn><publisher><publisher-name>Centers for Disease Control and Prevention</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">20113551</article-id><article-id pub-id-type="pmc">2957998</article-id><article-id pub-id-type="publisher-id">09-0571</article-id><article-id pub-id-type="doi">10.3201/eid1602.090571</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Cost-effectiveness of Pharmaceutical-based Pandemic Influenza Mitigation Strategies<xref ref-type="fn" rid="FN1"><sup>1</sup></xref></article-title><alt-title alt-title-type="running-head">Pandemic Influenza Mitigation Strategies</alt-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Newall</surname><given-names>Anthony T.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Wood</surname><given-names>James G.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Oudin</surname><given-names>Noemie</given-names></name></contrib><contrib contrib-type="author"><name><surname>MacIntyre</surname><given-names>C. Raina</given-names></name></contrib><aff id="aff1">University of New South Wales, Sydney, New South Wales, Australia (A.T. Newall, J.G. Wood, C.R. MacIntyre)</aff><aff id="aff2">National Institute for Applied Sciences, Lyon, France (N. Oudin)</aff></contrib-group><author-notes><corresp id="cor1">Address for correspondence: Anthony T. Newall, School of Public Health and Community Medicine, The University of New South Wales, Samuals Bldg, Sydney, New South Wales 2052, Australia; email: <email xlink:href="a.newall@unsw.edu.au">a.newall@unsw.edu.au</email></corresp></author-notes><pub-date pub-type="ppub"><month>2</month><year>2010</year></pub-date><volume>16</volume><issue>2</issue><fpage>224</fpage><lpage>230</lpage><abstract abstract-type="toc"><p>Population prepandemic vaccine and antiviral treatment strategies may be cost-effective.</p></abstract><abstract><p>We used a hybrid transmission and economic model to evaluate the relative merits of stockpiling antiviral drugs and vaccine for pandemic influenza mitigation. In the absence of any intervention, our base-case assumptions generated a population clinical attack rate of 31.1%. For at least some parameter values, population prepandemic vaccination strategies were effective at containing an outbreak of pandemic influenza until the arrival of a matched vaccine. Because of the uncertain nature of many parameters, we used a probabilistic approach to determine the most cost-effective strategies. At a willingness to pay of >A$24,000 per life-year saved, more than half the simulations showed that a prepandemic vaccination program combined with antiviral treatment was cost-effective in Australia.</p></abstract><kwd-group kwd-group-type="author"><title>Keywords: </title><kwd>Influenza</kwd><kwd>viruses</kwd><kwd>pandemic</kwd><kwd>mitigation</kwd><kwd>cost-effectiveness</kwd><kwd>vaccines</kwd><kwd>research</kwd></kwd-group></article-meta></front></pmc><affiliations><list></list><tree><noCountry><name sortKey="Macintyre, C Raina" sort="Macintyre, C Raina" uniqKey="Macintyre C" first="C. Raina" last="Macintyre">C. Raina Macintyre</name><name sortKey="Newall, Anthony T" sort="Newall, Anthony T" uniqKey="Newall A" first="Anthony T." last="Newall">Anthony T. Newall</name><name sortKey="Oudin, Noemie" sort="Oudin, Noemie" uniqKey="Oudin N" first="Noemie" last="Oudin">Noemie Oudin</name><name sortKey="Wood, James G" sort="Wood, James G" uniqKey="Wood J" first="James G." last="Wood">James G. Wood</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000713 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 000713 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= PMC:2957998
|texte= Cost-effectiveness of Pharmaceutical-based Pandemic Influenza Mitigation Strategies1
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:20113551" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |